Skip to main content
. 2021 Oct 27;43(3):1794–1804. doi: 10.3390/cimb43030126

Figure 2.

Figure 2

Western blot analysis of OF lysates and supernatants at baseline (D0) and after adipogenesis (DM15) from a GO patient (GO) and non-GO (NO); (A) antibody to TSHRv (B) 2C11 antibody to full-lengthTSHR. Neg; negative control (Secondary antibody only).